NIPT in the APAC Expected to Showcase Stupendous Growth

Consumer preference and growing popularity amongst healthcare providers are the key factors driving the market, says RNCOS.

 

Noida, UP -- (SBWIRE) -- 10/24/2014 -- As per the new research report by RNCOS, “Asia Pacific NIPT Market Outlook 2018” the market for non-invasive prenatal testing in the APAC region is growing at a fast rate. This growth can be credited to a number of factors, foremost of all being the high acceptance of NIPT tests amongst high-risk pregnant women. NIPT tests available in the region are majorly provided by established companies based in the US and China. The tests have been clinically validated for their claims of diagnosing chromosomal abnormalities while entirely eliminating the risk associated with invasive prenatal tests such as CVS and Amniocentesis, gaining them instant popularity amongst the consumers.

By and large, all the players have entered into tie-ups with locally established diagnostic service providers, increasing the access of tests to pregnant women. Further, since the tests have been clinically proven to be completely safe, this has made the tests popular amongst the healthcare providers who are now increasingly recommending NIPT test for screening purposes. Backed by such factors, the APAC NIPT market, constituting Australia, China, Japan and India, is expected to grow at a stupendous rate.

The report provides an in-depth analysis of the current market scenario and expected outlook by 2018. Regions covered in the report include Australia, India, Japan and China. Each region’s data coverage include the number of births, analysis of potential patient population that will form the customer base for NIPT tests, potential market, market size, forecasts, competitive landscape and regulatory scenario.

The report is an outcome of the in-depth analysis of insights generated through interviews with industry leaders and regulatory experts. All the data has been collated through various sources to present the most authentic and impartial picture. It is a must buy for any player that wishes to enter the highly lucrative APAC NIPT market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM714.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.